Island Pharmaceuticals Limited (ASX:ILA)

Australia flag Australia · Delayed Price · Currency is AUD
0.1900
+0.0200 (11.76%)
Aug 1, 2025, 4:10 PM AEST
11.76%
Market Cap46.97M
Revenue (ttm)399.37K
Net Income (ttm)-3.24M
Shares Out247.24M
EPS (ttm)-0.03
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,881,064
Average Volume779,570
Open0.1700
Previous Close0.1700
Day's Range0.1600 - 0.1900
52-Week Range0.0580 - 0.2800
Beta0.09
RSI60.25
Earnings DateAug 25, 2025

About Island Pharmaceuticals

Island Pharmaceuticals Limited, a drug research and repurposing company, focuses on the development of preventative or therapeutic drugs for viral infections in Australia and the United States of America. Its lead product candidate is ISLA-101, a drug for the prevention and treatment of dengue fever and other mosquito borne diseases. The company has a collaboration agreement with Monash University and National Cancer Institute IND. It also has a cooperative research and development agreement with the U.S. Army, Island in preparation for its Pha... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2017
Country Australia
Stock Exchange Australian Securities Exchange
Ticker Symbol ILA
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.